Stephen M. Shalet

18.9k total citations · 1 hit paper
268 papers, 13.7k citations indexed

About

Stephen M. Shalet is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stephen M. Shalet has authored 268 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Endocrinology, Diabetes and Metabolism, 56 papers in Molecular Biology and 55 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stephen M. Shalet's work include Growth Hormone and Insulin-like Growth Factors (174 papers), Pituitary Gland Disorders and Treatments (82 papers) and Childhood Cancer Survivors' Quality of Life (49 papers). Stephen M. Shalet is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (174 papers), Pituitary Gland Disorders and Treatments (82 papers) and Childhood Cancer Survivors' Quality of Life (49 papers). Stephen M. Shalet collaborates with scholars based in United Kingdom, United States and Germany. Stephen M. Shalet's co-authors include C G Beardwell, Andrew G. Renehan, Sarah O’Dwyer, Andrew Toogood, Ken Darzy, Matthias Egger, Christoph E. Minder, Marcel Zwahlen, William H. Wallace and Bernadette Brennan and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Stephen M. Shalet

266 papers receiving 13.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

2004 1.3k citations Andrew G. Renehan, Marcel Zwahlen et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen M. Shalet United Kingdom	66	8.2k	3.1k	3.0k	2.2k	1.7k	268	13.7k
Cheryl A. Conover United States	63	6.8k 0.8×	1.8k 0.6×	5.9k 2.0×	972 0.4×	1.7k 1.0×	239	13.8k
Paolo Beck‐Peccoz Italy	63	7.1k 0.9×	894 0.3×	2.6k 0.9×	928 0.4×	1.9k 1.1×	239	12.0k
Luca Persani Italy	58	5.7k 0.7×	948 0.3×	4.4k 1.4×	2.0k 0.9×	2.6k 1.5×	371	12.3k
Gaetano Lombardi Italy	86	17.9k 2.2×	843 0.3×	3.1k 1.0×	1.4k 0.6×	1.4k 0.8×	445	24.2k
John Wass United Kingdom	78	14.4k 1.8×	463 0.1×	3.3k 1.1×	975 0.4×	1.9k 1.1×	358	20.9k
Martin O. Savage United Kingdom	57	8.9k 1.1×	1.5k 0.5×	2.7k 0.9×	366 0.2×	3.4k 2.0×	268	12.8k
Terry F. Davies United States	61	7.8k 1.0×	524 0.2×	3.3k 1.1×	561 0.2×	3.7k 2.2×	349	13.4k
Zvi Laron Israel	51	6.7k 0.8×	1.2k 0.4×	3.6k 1.2×	373 0.2×	3.0k 1.8×	399	10.5k
Victor K. M. Han Canada	49	2.5k 0.3×	1.9k 0.6×	2.4k 0.8×	533 0.2×	1.2k 0.7×	160	7.3k
Ken K. Y. Ho Australia	53	8.6k 1.0×	955 0.3×	2.1k 0.7×	294 0.1×	1.8k 1.1×	186	11.5k

Countries citing papers authored by Stephen M. Shalet

Since Specialization

Citations

This map shows the geographic impact of Stephen M. Shalet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Shalet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Shalet more than expected).

Fields of papers citing papers by Stephen M. Shalet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen M. Shalet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Shalet. The network helps show where Stephen M. Shalet may publish in the future.

Co-authorship network of co-authors of Stephen M. Shalet

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Shalet. A scholar is included among the top collaborators of Stephen M. Shalet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Shalet. Stephen M. Shalet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murray, Robert, et al.. (2009). Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima‐medial thickness. Clinical Endocrinology. 73(4). 508–515. 20 indexed citations

Karbownik‐Lewińska, Małgorzata, et al.. (2007). GH replacement reduces increased lipid peroxidation in GH‐deficient adults. Clinical Endocrinology. 68(6). 957–964. 10 indexed citations

Cilliers, Deirdre, Peter Clayton, S A Cairns, et al.. (2007). A new X-linked mental retardation (XLMR) syndrome with late-onset primary testicular failure, short stature and microcephaly maps to Xq25–q26. European Journal of Medical Genetics. 50(3). 216–223. 2 indexed citations

Renehan, Andrew G., Marcel Zwahlen, Sarah O’Dwyer, Stephen M. Shalet, & Matthias Egger. (2004). IGF-1, IGFBP-3, and cancer risk. The Lancet. 364(9431). 326–327. 1 indexed citations

Mukherjee, Annice, et al.. (2003). Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic–pituitary axis. Clinical Endocrinology. 59(6). 743–748. 36 indexed citations

Murray, Robert, et al.. (2002). Spinal irradiation impairs the osteo‐anabolic effects of low‐dose GH replacement in adults with childhood‐onset GH deficiency. Clinical Endocrinology. 56(2). 169–174. 9 indexed citations

Shalet, Stephen M., et al.. (2002). Acromegaly and colorectal cancer: risk assessment should be based on population-based studies; author reply .. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1909–1909. 2 indexed citations

Renehan, Andrew G., Andrew Toogood, W. David J. Ryder, et al.. (2001). Paradoxical elevations in serum IGF‐II and IGF binding protein‐2 in acromegaly: insights into the regulation of these peptides. Clinical Endocrinology. 55(4). 469–475. 10 indexed citations

Shalet, Stephen M.. (2000). Growth Hormone (GH) Replacement Is Not Justified for All Adults with GH Deficiency. The Journal of Clinical Endocrinology & Metabolism. 85(3). 937–939. 1 indexed citations

10.

Renehan, Andrew G., Jim R. Jones, Christopher S. Potten, Stephen M. Shalet, & S T O’Dwyer. (2000). Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. British Journal of Cancer. 83(10). 1344–1350. 97 indexed citations

11.

Toogood, Andrew & Stephen M. Shalet. (1998). Conflicts with the sornatopause. Growth Hormone & IGF Research. 8. 47–54. 10 indexed citations

12.

Shalet, Stephen M.. (1991). Growth hormone therapy following bone marrow transplantation in childhood.. PubMed. 8 Suppl 1. 14–14. 2 indexed citations

13.

Littley, M D & Stephen M. Shalet. (1989). Diagnosis of adrenal insufficiency. BMJ. 298(6674). 669.2–669.

14.

Littley, M D, et al.. (1989). Hypopituitarism Following External Radiotherapy for Pituitary Tumours in Adults. QJM. 70(262). 145–60. 321 indexed citations

15.

Shalet, Stephen M., et al.. (1985). Pregnancy after chemotherapy induced ovarian failure.. BMJ. 290(6472). 898.1–898. 5 indexed citations

16.

Ahmed, S R, et al.. (1985). Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.. BMJ. 290(6463). 185–187. 50 indexed citations

17.

Shalet, Stephen M., et al.. (1985). Leydig cell damage after testicular irradiation for lymphoblastic leukaemia. Medical and Pediatric Oncology. 13(2). 65–68. 53 indexed citations

18.

Ahmed, S R, Stephen M. Shalet, C G Beardwell, & Maurice Sutton. (1984). Treatment of Cushing's disease with low dose radiation therapy.. BMJ. 289(6446). 643–646. 29 indexed citations

19.

Ahmed, S R, Stephen M. Shalet, R. H. A. Campbell, & D.P. Deakin. (1983). Primary gonadal damage following treatment of brain tumors in childhood. The Journal of Pediatrics. 103(4). 562–565. 56 indexed citations

20.

MacFarlane, I. A., et al.. (1979). Hyperhidrosis in acromegaly: effectiveness of topical aluminium chloride hexahydrate solution.. BMJ. 2(6195). 901–902. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact